FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2061438544> ?p ?o ?g. }

• W2061438544 endingPage "915" @default.
• W2061438544 startingPage "905" @default.
• W2061438544 abstract "Background Since the bundled end-stage renal disease prospective payment system began in 2011 in the United States, some hemodialysis practices have changed substantially, raising the question of whether vascular access practice also has changed. We describe monthly US vascular access use from August 2010 to August 2013 with international comparisons, and other aspects of US vascular access practice. Study Design Prospective observational cohort study of vascular access. Setting & Participants Maintenance hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Practice Monitor (DPM) in the United States (N = 3,442; US patients) and 19 other nations (N = 8,478). Predictors Country, patient demographics, time period. Outcomes Vascular access use, pre–end-stage renal disease access timing of first nephrologist care and arteriovenous access placement, patient self-reported vascular access preferences (United States only), treatment practices as stated by medical directors. Results In the United States from August 2010 to August 2013, arteriovenous fistula (AVF) use increased from 63% to 68%, while catheter use declined from 19% to 15%. Although AVF use did not differ greatly across age groups, arteriovenous graft use was 2-fold higher among black (26%) versus nonblack US patients (13%) in 2013. Across 20 countries in 2013, AVF use ranged from 49% to 92%, whereas catheter use ranged from 1% to 45%. Patient-reported vascular access preferences differed by sex and race, with 16% to 20% of patients feeling uninformed regarding benefits/risks of different vascular access types. Among new (incident) US hemodialysis patients, AVF use remains low, with ∼70% initiating hemodialysis therapy with a catheter (60% starting with catheter when having ≥4 months of predialysis nephrology care). In the United States, longer typical times to first AVF cannulation were reported. Limitations Noncompletion of surveys may affect the generalizability of findings to the wider hemodialysis population. Conclusions AVF use has increased, with catheter use decreasing among prevalent US hemodialysis patients since the introduction of the prospective payment system. However, AVF use at dialysis therapy initiation remains low, suggesting that reforms affecting predialysis care may be necessary to incentivize improvements in fistula rates at dialysis therapy initiation as achieved for prevalent hemodialysis patients. Since the bundled end-stage renal disease prospective payment system began in 2011 in the United States, some hemodialysis practices have changed substantially, raising the question of whether vascular access practice also has changed. We describe monthly US vascular access use from August 2010 to August 2013 with international comparisons, and other aspects of US vascular access practice. Prospective observational cohort study of vascular access. Maintenance hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS) Practice Monitor (DPM) in the United States (N = 3,442; US patients) and 19 other nations (N = 8,478). Country, patient demographics, time period. Vascular access use, pre–end-stage renal disease access timing of first nephrologist care and arteriovenous access placement, patient self-reported vascular access preferences (United States only), treatment practices as stated by medical directors. In the United States from August 2010 to August 2013, arteriovenous fistula (AVF) use increased from 63% to 68%, while catheter use declined from 19% to 15%. Although AVF use did not differ greatly across age groups, arteriovenous graft use was 2-fold higher among black (26%) versus nonblack US patients (13%) in 2013. Across 20 countries in 2013, AVF use ranged from 49% to 92%, whereas catheter use ranged from 1% to 45%. Patient-reported vascular access preferences differed by sex and race, with 16% to 20% of patients feeling uninformed regarding benefits/risks of different vascular access types. Among new (incident) US hemodialysis patients, AVF use remains low, with ∼70% initiating hemodialysis therapy with a catheter (60% starting with catheter when having ≥4 months of predialysis nephrology care). In the United States, longer typical times to first AVF cannulation were reported. Noncompletion of surveys may affect the generalizability of findings to the wider hemodialysis population. AVF use has increased, with catheter use decreasing among prevalent US hemodialysis patients since the introduction of the prospective payment system. However, AVF use at dialysis therapy initiation remains low, suggesting that reforms affecting predialysis care may be necessary to incentivize improvements in fistula rates at dialysis therapy initiation as achieved for prevalent hemodialysis patients." @default.
• W2061438544 created "2016-06-24" @default.
• W2061438544 creator A5035826601 @default.
• W2061438544 creator A5046097512 @default.
• W2061438544 creator A5057956524 @default.
• W2061438544 creator A5083226860 @default.
• W2061438544 date "2015-06-01" @default.
• W2061438544 modified "2023-10-17" @default.
• W2061438544 title "Trends in US Vascular Access Use, Patient Preferences, and Related Practices: An Update From the US DOPPS Practice Monitor With International Comparisons" @default.
• W2061438544 cites W1568679108 @default.
• W2061438544 cites W1957241200 @default.
• W2061438544 cites W1963637086 @default.
• W2061438544 cites W1964826356 @default.
• W2061438544 cites W1968324276 @default.
• W2061438544 cites W1972109683 @default.
• W2061438544 cites W1977296329 @default.
• W2061438544 cites W1979187236 @default.
• W2061438544 cites W1979753979 @default.
• W2061438544 cites W1991743499 @default.
• W2061438544 cites W1991774389 @default.
• W2061438544 cites W1995729033 @default.
• W2061438544 cites W1996504640 @default.
• W2061438544 cites W2001004568 @default.
• W2061438544 cites W2002298764 @default.
• W2061438544 cites W2007990349 @default.
• W2061438544 cites W2013507026 @default.
• W2061438544 cites W2019931241 @default.
• W2061438544 cites W2022331738 @default.
• W2061438544 cites W2030328539 @default.
• W2061438544 cites W2031316562 @default.
• W2061438544 cites W2039557862 @default.
• W2061438544 cites W2042846697 @default.
• W2061438544 cites W2060566444 @default.
• W2061438544 cites W2060792653 @default.
• W2061438544 cites W2068133286 @default.
• W2061438544 cites W2069557069 @default.
• W2061438544 cites W2070509399 @default.
• W2061438544 cites W2077119527 @default.
• W2061438544 cites W2090317482 @default.
• W2061438544 cites W2091665068 @default.
• W2061438544 cites W2098577659 @default.
• W2061438544 cites W2103938451 @default.
• W2061438544 cites W2106786889 @default.
• W2061438544 cites W2111954562 @default.
• W2061438544 cites W2113525652 @default.
• W2061438544 cites W2116547763 @default.
• W2061438544 cites W2116701785 @default.
• W2061438544 cites W2119355594 @default.
• W2061438544 cites W2125297058 @default.
• W2061438544 cites W2134422414 @default.
• W2061438544 cites W2134628290 @default.
• W2061438544 cites W2138678834 @default.
• W2061438544 cites W2139537766 @default.
• W2061438544 cites W2140819650 @default.
• W2061438544 cites W2142968294 @default.
• W2061438544 cites W2145586947 @default.
• W2061438544 cites W2148042420 @default.
• W2061438544 cites W2149745409 @default.
• W2061438544 cites W2152703652 @default.
• W2061438544 cites W2153426184 @default.
• W2061438544 cites W2155679751 @default.
• W2061438544 cites W2161930722 @default.
• W2061438544 cites W2164107387 @default.
• W2061438544 cites W3105521198 @default.
• W2061438544 cites W4245495994 @default.
• W2061438544 doi "https://doi.org/10.1053/j.ajkd.2014.12.014" @default.
• W2061438544 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25662834" @default.
• W2061438544 hasPublicationYear "2015" @default.
• W2061438544 type Work @default.
• W2061438544 sameAs 2061438544 @default.
• W2061438544 citedByCount "224" @default.
• W2061438544 countsByYear W20614385442015 @default.
• W2061438544 countsByYear W20614385442016 @default.
• W2061438544 countsByYear W20614385442017 @default.
• W2061438544 countsByYear W20614385442018 @default.
• W2061438544 countsByYear W20614385442019 @default.
• W2061438544 countsByYear W20614385442020 @default.
• W2061438544 countsByYear W20614385442021 @default.
• W2061438544 countsByYear W20614385442022 @default.
• W2061438544 countsByYear W20614385442023 @default.
• W2061438544 crossrefType "journal-article" @default.
• W2061438544 hasAuthorship W2061438544A5035826601 @default.
• W2061438544 hasAuthorship W2061438544A5046097512 @default.
• W2061438544 hasAuthorship W2061438544A5057956524 @default.
• W2061438544 hasAuthorship W2061438544A5083226860 @default.
• W2061438544 hasConcept C126322002 @default.
• W2061438544 hasConcept C141071460 @default.
• W2061438544 hasConcept C177713679 @default.
• W2061438544 hasConcept C188816634 @default.
• W2061438544 hasConcept C194828623 @default.
• W2061438544 hasConcept C23131810 @default.
• W2061438544 hasConcept C2776016174 @default.
• W2061438544 hasConcept C2778063415 @default.
• W2061438544 hasConcept C2779063477 @default.
• W2061438544 hasConcept C2779978075 @default.
• W2061438544 hasConcept C54847362 @default.
• W2061438544 hasConcept C71924100 @default.
• W2061438544 hasConceptScore W2061438544C126322002 @default.

• next